Sample Size Reestimation: A Review and Recommendations
暂无分享,去创建一个
Paul Gallo | Keaven Anderson | Christy Chuang-Stein | Sylva Collins | P. Gallo | C. Chuang-Stein | K. Anderson | Sylva Collins
[1] Donald A. Berry,et al. Statistical Innovations in Cancer Research , 2003 .
[2] Yuliya Lokhnygina. Topics in design and analysis of clinical trials. , 2004 .
[3] T. Friede,et al. A comparison of methods for adaptive sample size adjustment , 2001, Statistics in medicine.
[4] A. Gould. Planning and revising the sample size for a trial. , 1995, Statistics in Medicine.
[5] Cyrus R Mehta,et al. Adaptive, group sequential and decision theoretic approaches to sample size determination , 2006, Statistics in medicine.
[6] D. Siegmund. Sequential Analysis: Tests and Confidence Intervals , 1985 .
[7] A. Tsiatis,et al. On the inefficiency of the adaptive design for monitoring clinical trials , 2003 .
[8] R. Muirhead,et al. Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America , 2007 .
[9] P. Bauer,et al. The reassessment of trial perspectives from interim data—a critical view , 2006, Statistics in medicine.
[10] C. Burman,et al. Are Flexible Designs Sound? , 2006, Biometrics.
[11] T. Friede,et al. Sample size recalculation for binary data in internal pilot study designs , 2004 .
[12] M. Krams,et al. Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group , 2006, Journal of biopharmaceutical statistics.
[13] Alex Dmitrienko,et al. Analysis of Clinical Trials Using SAS: A Practical Guide , 2005 .
[14] Michael A Proschan,et al. Two-Stage Sample Size Re-Estimation Based on a Nuisance Parameter: A Review , 2005, Journal of biopharmaceutical statistics.
[15] Christopher Jennison,et al. Are flexible designs sound? Discussion , 2006 .
[16] Meinhard Kieser,et al. Simple procedures for blinded sample size adjustment that do not affect the type I error rate , 2003, Statistics in medicine.
[17] W. Lehmacher,et al. Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.
[18] Sue-Jane Wang,et al. Modification of Sample Size in Group Sequential Clinical Trials , 1999, Biometrics.
[19] Alan Y. Chiang,et al. Data Analysis of Asymmetric Structures: Advanced Approaches in Computational Statistics , 2006, Technometrics.
[20] Christopher Jennison,et al. Mid‐course sample size modification in clinical trials based on the observed treatment effect , 2002, Statistics in medicine.
[21] Anastasios A Tsiatis,et al. Adaptive two‐stage designs in phase II clinical trials , 2006, Statistics in medicine.
[22] Anastasios A. Tsiatis,et al. Flexible Sample Size Considerations Using Information-Based Interim Monitoring , 2001 .
[23] Christopher Jennison,et al. Efficient group sequential designs when there are several effect sizes under consideration , 2006, Statistics in medicine.
[24] M A Proschan,et al. Designed extension of studies based on conditional power. , 1995, Biometrics.
[25] B. Turnbull,et al. Group Sequential Methods , 1999 .
[26] Martin Posch,et al. Issues in designing flexible trials , 2003, Statistics in medicine.
[27] M. Proschan,et al. Designed extension of studies based on conditional power. , 1995 .
[28] A L Gould,et al. Sample size re‐estimation: recent developments and practical considerations , 2001, Statistics in medicine.
[29] Christopher Jennison,et al. Adaptive and nonadaptive group sequential tests , 2006 .
[30] G. Chi,et al. On Sample Size and Inference for Two‐Stage Adaptive Designs , 2001, Biometrics.
[31] W. Shih. Sample size re‐estimation – journey for a decade , 2001, Statistics in medicine.